Matches in Nanopublications for { ?s ?p "[p53 is usually inactivated by point mutations during tumorigenesis, whereas the expression levels and p63 and p73 are modulated to give tumor cells a selective advantage.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- NP767975.RAc_CEHuwnOxICqG74ZK3ySmUVl0u1485LwmNItFTs3iw130_assertion description "[p53 is usually inactivated by point mutations during tumorigenesis, whereas the expression levels and p63 and p73 are modulated to give tumor cells a selective advantage.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP767975.RAc_CEHuwnOxICqG74ZK3ySmUVl0u1485LwmNItFTs3iw130_provenance.
- NP799774.RAfnVthVfMYucQr5a0elr5zXi5Nf1kCKBjOotTaD4_yzw130_assertion description "[p53 is usually inactivated by point mutations during tumorigenesis, whereas the expression levels and p63 and p73 are modulated to give tumor cells a selective advantage.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP799774.RAfnVthVfMYucQr5a0elr5zXi5Nf1kCKBjOotTaD4_yzw130_provenance.
- NP800846.RAco4OskeB8-RD6ICKw6jxvFH88poLjAtWV33azkGD8Zs130_assertion description "[p53 is usually inactivated by point mutations during tumorigenesis, whereas the expression levels and p63 and p73 are modulated to give tumor cells a selective advantage.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP800846.RAco4OskeB8-RD6ICKw6jxvFH88poLjAtWV33azkGD8Zs130_provenance.
- NP800848.RAtoYnQRclJyfTO85-gII0rXEcc6XKJDOzS-u3Z4kvzXQ130_assertion description "[p53 is usually inactivated by point mutations during tumorigenesis, whereas the expression levels and p63 and p73 are modulated to give tumor cells a selective advantage.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP800848.RAtoYnQRclJyfTO85-gII0rXEcc6XKJDOzS-u3Z4kvzXQ130_provenance.
- NP674913.RA8oAQfRFOih2c9u91o-JxiJp_ZmMOpKbxXFS2YW59o34130_assertion description "[p53 is usually inactivated by point mutations during tumorigenesis, whereas the expression levels and p63 and p73 are modulated to give tumor cells a selective advantage.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP674913.RA8oAQfRFOih2c9u91o-JxiJp_ZmMOpKbxXFS2YW59o34130_provenance.
- NP800845.RAJOGsC8dgRmsTeF7i71HWaphtE6E9akqJ6dbCwBwk2y4130_assertion description "[p53 is usually inactivated by point mutations during tumorigenesis, whereas the expression levels and p63 and p73 are modulated to give tumor cells a selective advantage.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP800845.RAJOGsC8dgRmsTeF7i71HWaphtE6E9akqJ6dbCwBwk2y4130_provenance.
- NP800847.RAHOqQMXaIQjDJNcJ3foMmcpX-eZo0ZQFEWOMXkR9cWV4130_assertion description "[p53 is usually inactivated by point mutations during tumorigenesis, whereas the expression levels and p63 and p73 are modulated to give tumor cells a selective advantage.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP800847.RAHOqQMXaIQjDJNcJ3foMmcpX-eZo0ZQFEWOMXkR9cWV4130_provenance.
- NP857188.RA8SU17AS70yteibxJRfX6J18pbgJIceEX_mbYyAwuOvs130_assertion description "[p53 is usually inactivated by point mutations during tumorigenesis, whereas the expression levels and p63 and p73 are modulated to give tumor cells a selective advantage.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP857188.RA8SU17AS70yteibxJRfX6J18pbgJIceEX_mbYyAwuOvs130_provenance.